This rearch study is for men and women who are admitted to the hospital for ST-elevated myocardial infarction (STEMI, or “heart attack”). The purpose of the study is to test whether cardiac echocardiography (“echo”) can detect blood clots, or “thrombi,” more effectively in these patients if it is performed with the addition of perflutren lipid microspheres, a contrast agent that is approved by the Food and Drug Administration (FDA) to improve detection of thrombi with echo in selected populations.
Improving detection of thrombi may help physicians to predict the risk of STEMI patients for stroke.
Admission to the hospital for STEMI. Only patients who enroll in the “Cardiac MRI for Post MI Thrombi and PMI” study are permitted to enroll.
Detailed eligibility requirements will be reviewed when you contact the study team.
Meenakshi Das Das Lala, phone 212-746-3412, email email@example.com
Diagnostic Utility of Contrast Echocardiography for Detection of Left Ventricular Thrombi Post ST Elevation Myocardial Infarction.